Audio By Vocalize
Women and girls who are sexually active have been warned against using a falsified batch of the emergency contraceptive Postinor-2 circulating in the Kenyan market.
The Pharmacy and Poisons Board (PPB) raised the alarm after identifying falsified Postinor-2 (Levonorgestrel 0.75mg tablets), warning that the medicine may contain incorrect amounts of the active ingredient, no active ingredient at all, harmful contaminants or undeclared substances.
The regulator said the falsified product may therefore fail to provide the intended therapeutic effect, potentially exposing women relying on emergency contraception to unintended pregnancies.
The affected product is Postinor-2, Batch No. T34197R, which falsely claims to have been manufactured by pharmaceutical company Gedeon Richter.
